198 related articles for article (PubMed ID: 28928007)
1. Removal of uremic retention products by hemodialysis is coupled with indiscriminate loss of vital metabolites.
Zhang ZH; Mao JR; Chen H; Su W; Zhang Y; Zhang L; Chen DQ; Zhao YY; Vaziri ND
Clin Biochem; 2017 Dec; 50(18):1078-1086. PubMed ID: 28928007
[TBL] [Abstract][Full Text] [Related]
2. Effect of Different Hemodialysis Methods on Microbiota in Uremic Patients.
He H; Xie Y
Biomed Res Int; 2020; 2020():6739762. PubMed ID: 32685517
[TBL] [Abstract][Full Text] [Related]
3. Red blood cell calcium homeostasis in patients with end-stage renal disease.
Gafter U; Malachi T; Barak H; Djaldetti M; Levi J
J Lab Clin Med; 1989 Sep; 114(3):222-31. PubMed ID: 2527934
[TBL] [Abstract][Full Text] [Related]
4. Metabolite Profiling of Feces and Serum in Hemodialysis Patients and the Effect of Medicinal Charcoal Tablets.
Liu S; Liang S; Liu H; Chen L; Sun L; Wei M; Jiang H; Wang J
Kidney Blood Press Res; 2018; 43(3):755-767. PubMed ID: 29804117
[TBL] [Abstract][Full Text] [Related]
5. Antithrombin deficiency in end-stage renal disease associated with paraplegia: effect of hemodialysis.
Vaziri ND; Winer RL; Alikhani S; Danviryasup K; Toohey J; Hung E; Gordon S; Eltorai I; Paule P
Arch Phys Med Rehabil; 1985 May; 66(5):307-9. PubMed ID: 3924003
[TBL] [Abstract][Full Text] [Related]
6. Hemodialysis clearance of chloroquine in uremic patients.
Akintonwa A; Odutola TA; Edeki T; Mabadeje AF
Ther Drug Monit; 1986; 8(3):285-7. PubMed ID: 3750371
[TBL] [Abstract][Full Text] [Related]
7. Effect of hemodialysis on serum concentrations of HPLC-analyzed accumulating solutes in uremia.
Schoots AC; Peeters JA; Gerlag PG
Nephron; 1989; 53(3):208-17. PubMed ID: 2507950
[TBL] [Abstract][Full Text] [Related]
8. Exploring blood alterations in chronic kidney disease and haemodialysis using metabolomics.
Gagnebin Y; Jaques DA; Rudaz S; de Seigneux S; Boccard J; Ponte B
Sci Rep; 2020 Nov; 10(1):19502. PubMed ID: 33177589
[TBL] [Abstract][Full Text] [Related]
9. 18-Hydroxy-11-deoxycorticosterone in hypertensive uremic patients during hemodialysis.
Sparano F; Giaquinto G; Odoardi A; Mercuri MA; Tosti-Croce C; Sulon J; Sciarra F
Horm Res; 1979; 10(5):282-8. PubMed ID: 457038
[TBL] [Abstract][Full Text] [Related]
10. Hemodialysis-associated platelet loss: study of the relative contribution of dialyzer membrane composition and geometry.
Docci D; Turci F; Del Vecchio C; Bilancioni R; Cenciotti L; Pretolani E
Int J Artif Organs; 1984 Nov; 7(6):337-40. PubMed ID: 6526528
[TBL] [Abstract][Full Text] [Related]
11. Assay of serum abnormalities in uremic and dialysis patients. Evidence for depletion of vital substances in hemodialysis.
Quadracci LJ; Cambi V; Christopher TG; Harker LA; Striker GE
Trans Am Soc Artif Intern Organs; 1971; 17():96-101. PubMed ID: 5158140
[No Abstract] [Full Text] [Related]
12. Liquid-chromatographic study of fluorescent materials in uremic fluids.
Swan JS; Kragten EY; Veening H
Clin Chem; 1983 Jun; 29(6):1082-4. PubMed ID: 6851098
[TBL] [Abstract][Full Text] [Related]
13. Identification of some abnormal metabolites in plasma from uremic subjects.
Bultitude FW; Newham SJ
Clin Chem; 1975 Aug; 21(9):1329-34. PubMed ID: 1149237
[TBL] [Abstract][Full Text] [Related]
14. Factors in the dialysis regimen which contribute to alterations in the abnormalities of uremia.
Lowrie EG; Steinberg SM; Galen MA; Gagneux SA; Lazarus JM; Gottlieb MN; Merrill JP
Kidney Int; 1976 Nov; 10(5):409-22. PubMed ID: 1003730
[TBL] [Abstract][Full Text] [Related]
15. Do only small uremic toxins, chromophores, contribute to the online dialysis dose monitoring by UV absorbance?
Arund J; Tanner R; Uhlin F; Fridolin I
Toxins (Basel); 2012 Oct; 4(10):849-61. PubMed ID: 23162701
[TBL] [Abstract][Full Text] [Related]
16. The metabolism of human serum albumin in renal failure on conservative and dialysis therapy.
Bianchi R; Mariani G; Toni MG; Carmassi F
Am J Clin Nutr; 1978 Sep; 31(9):1615-26. PubMed ID: 685877
[TBL] [Abstract][Full Text] [Related]
17. Oxalate removal by hemodialysis in end-stage renal disease.
Ramsay AG; Reed RG
Am J Kidney Dis; 1984 Sep; 4(2):123-7. PubMed ID: 6475942
[TBL] [Abstract][Full Text] [Related]
18. Plasma and muscle free amino acids in maintenance hemodialysis patients without protein malnutrition.
Bergström J; Alvestrand A; Fürst P
Kidney Int; 1990 Jul; 38(1):108-14. PubMed ID: 2117095
[TBL] [Abstract][Full Text] [Related]
19. Hemodialysis and erythrocyte epoxy fatty acids.
Gollasch B; Wu G; Liu T; Dogan I; Rothe M; Gollasch M; Luft FC
Physiol Rep; 2020 Oct; 8(20):e14601. PubMed ID: 33112511
[TBL] [Abstract][Full Text] [Related]
20. Proteomic Investigations into Hemodialysis Therapy.
Bonomini M; Sirolli V; Pieroni L; Felaco P; Amoroso L; Urbani A
Int J Mol Sci; 2015 Dec; 16(12):29508-21. PubMed ID: 26690416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
